Launch
Website- Bupa Platinum consultant
- Fee assured
- Verified account
- Open Referral network
Specialises in
- Colon
- Hepatobiliary
- Lower GI
Offers
- Face-to-face consultations
- Video and telephone consultations
- Home chemotherapy
About me
I am a consultant oncologist specialising in bowel, pancreatic, and liver cancers, as well as other cancers that have spread to the liver, lungs, lymph nodes, bones or spine. I have 20 years' experience in cancer medicine, using drug treatments such as chemotherapy, immunotherapy and targeted cancer drugs alongside radiotherapy techniques-- including highly focused SABR treatment and MRI-guided radiotherapy.
My approach is straightforward and supportive. I explain each option clearly: what it aims to do, how it will affect you, and how the different treatments may fit together. I work closely with surgeons and other specialists to create a joined-up plan.
I have been actively involved in national and international clinical trials. This helps me advise on newer evidence-based options as well as established treatments, including whether additional testing of the cancer or a clinical trial may be helpful.
Many patients come to me for a second opinion when they want reassurance that every suitable option has been considered. This is especially common when cancer has spread, treatment options are uncertain or not straightforward, the cancer has returned after previous treatment, or when surgery, drug treatment and radiotherapy need to be carefully coordinated.
The main areas of my private practice are:
++Bowel cancer treatment and second opinions
Patients with newly diagnosed bowel or rectal cancer, whether confined to the bowel or spread to other organs, need rapid access to a carefully coordinated plan. I provide advice on chemotherapy, immunotherapy, targeted cancer drugs, radiotherapy and SABR, as well as testing the cancer for genetic changes that may affect treatment choices. I also discuss lifestyle measures that may help you tolerate treatment, preserve quality of life and get the best possible outcome.
++SABR and MRI-guided radiotherapy
I have nationally leading expertise in using highly focused radiotherapy to treat a small number of cancer deposits, including difficult-to-treat areas and cancer that has come back after previous radiotherapy. I help patients from across the UK with all types of secondary cancer, including people with breast, prostate, lung, skin and other cancers as well as gastrointestinal cancer, where SABR may be appropriate.
++Pancreatic cancer treatment strategy
I have pioneered the use of high-dose MRI-guided radiotherapy for people with pancreatic cancer alongside chemotherapy, including cancers that cannot currently be removed by surgery and tumours that have spread to other parts of the body.
++Liver, bile duct and secondary cancer reviews
I see patients who need advice about how best to combine drug treatment, radiotherapy, surgery, ablation, specialist liver treatments or clinical trials.
Alongside my NHS consultant role at University Hospitals Birmingham, I am Clinical Director for Stereotactic and MRI-guided Radiotherapy at GenesisCare, the leading UK private provider of advanced radiotherapy.
My goal is to help patients and families face difficult cancer treatment decisions with clear information, expert advice and greater confidence.
Areas of interest
Bowel cancer; Cholangiocarcinoma; Colon cancer; Liver cancer; Liver metastases; Pancreatic cancer; Rectal cancer; Chemotherapy; CyberKnife; Immunotherapy; MRI-guided radiotherapy; Personalised medicine; Radiotherapy; SABR; SBRT; SIRT;
Medical secretaries
- Laura Evans
- 020 3031 3523
- enquire@drjamesgood.com
Information for healthcare professionals (Bupa patients only, last 12 months)
-
A1080
Stereotactic radiotherapy (SRT), second to fifth sessions, including adjustments, using Cyberknife or similar SRT technology - (>50)
GenesisCare, Oxford (5-50) GenesisCare, Birmingham (5-50)
-
X0004
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (5-50)
Spire Little Aston Hospital (5-50)
-
X0003
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (5-50)
HCA Healthcare UK The Harborne Hospital (5-50) Spire Little Aston Hospital (1-5)
-
A1070
Stereotactic radiotherapy (SRT), first/sole session using Cyberknife or similar SRT technology - (5-50)
GenesisCare, Oxford (5-50) GenesisCare, Birmingham (1-5)
-
X0002
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-14 days - (5-50)
Spire Little Aston Hospital (5-50) HCA Healthcare UK The Harborne Hospital (5-50) GenesisCare, Oxford (1-5)
- Show All (8 )...